Tollys presents scientific data supporting preclinical proof of concept for TL-532, its cancer immunotherapy drug candidate

Logo Tollys

 

Doctors Marc Bonnin and Sylvain Thierry will present Tollys’ results at the European Association of Cancer Research’s EACR 2021 Congress, which will take place from June 9 -12

Read the article (EN)

– PDF : Tollys presents scientific data supporting preclinical proof of concept for TL-532, its cancer immunotherapy drug candidate

Lire l'article (FR)

– PDF : Tollys présente les données scientifiques de preuve de concept préclinique de son candidat TL-532 en immunothérapie du cancer

Return

Tollys

A new dimension in immuno-oncology

Office

60F avenue Rockefeller
69008 Lyon, FRANCE

Contact us

contact@tollys.fr